A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
一项从临床到实验室的抗PD-1、抗CD40和抗CSF1R研究表明,剂量越多并不一定越好。
期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-023-01884-x
Djureinovic, Dijana; Weiss, Sarah A; Krykbaeva, Irina; Qu, Rihao; Vathiotis, Ioannis; Moutafi, Myrto; Zhang, Lin; Perdigoto, Ana L; Wei, Wei; Anderson, Gail; Damsky, William; Hurwitz, Michael; Johnson, Barbara; Schoenfeld, David; Mahajan, Amit; Hsu, Frank; Miller-Jensen, Kathryn; Kluger, Yuval; Sznol, Mario; Kaech, Susan M; Bosenberg, Marcus; Jilaveanu, Lucia B; Kluger, Harriet M